US Stock MarketDetailed Quotes

RAPP Rapport Therapeutics

Watchlist
  • 25.670
  • -0.220-0.85%
Close Jul 12 16:00 ET
  • 25.390
  • -0.280-1.09%
Post 16:41 ET
938.92MMarket Cap-17703P/E (TTM)

About Rapport Therapeutics Company

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Company Profile

SymbolRAPP
Company NameRapport Therapeutics
Listing DateJun 7, 2024
Issue Price17.00
Founded2022
CEOMr. Abraham N. Ceesay, M.B.A.
MarketNASDAQ
Employees58
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1325 Boylston Street,Suite 401
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02215
Phone1-857-321-8020
Websitehttp://www.rapportrx.com

Company Executives

  • Name
  • Position
  • Salary
  • Abraham N. Ceesay, M.B.A.
  • Chief Executive Officer and Director
  • 2.42M
  • Dr. Swamy Yeleswaram, PhD
  • Chief Development Officer
  • --
  • Dr. Bradley S. Galer, M.D.
  • Chief Medical Officer
  • --
  • Kathy Wilkinson
  • Chief People Officer
  • --
  • David Bredt, M.D.,PhD
  • Chief Scientific Officer and Director
  • --
  • Cheryl Gault
  • Chief Operating Officer
  • 1.78M
  • Troy A. Ignelzi
  • Chief Financial Officer
  • 2.13M
  • Dr. Steven M. Paul, M.D.
  • Chairman of the Board
  • 568.99K
  • Raymond Kelleher, M.D.,PhD
  • Director
  • --
  • Dr. Jeffrey K. Tong, PhD
  • Director
  • 55.50K
  • Dr. Reid M. Huber, PhD
  • Director
  • 400.26K
  • Dr. James I. Healy, M.D.,PhD
  • Director
  • --
  • Terry-Ann Burrell, M.B.A.
  • Director
  • --
  • Dr. John M. Maraganore,PhD
  • Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Recent IPOs
Recent IPOs
Intraday+1.30%